Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

2seventybio

Biotech & Life Sciences · Cambridge, United States · Founded 2021 · IPO 2021 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$100–500M
Latest valuation · 2026
Unlock exact value
Revenue
$10–50M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

11 investors on 2seventybio's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 11 investors entered at this stage
683 Capital
Casdin Capital
EcoR1 Capital
Cowen Healthcare Investments
Bain Capital Life Sciences
Janus Henderson Investors
Boxer Capital
CaaS Capital Management
Heights Capital Management
RTW Investments
Armistice Capital

Global footprint

Where 2seventybio has talent and traffic

Web traffic by country
920 monthly visits
across markets
🇺🇸 United States97.8%
Top 1 markets shown

See 2seventybio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo